Latest Conference Articles

Associating Genes With Melanoma Risk

Associating Genes With Melanoma Risk

October 19th 2017, 5:57pm

World Congress on Melanoma

Maria T. Landi, M.D., Ph.D., principal investigator at the National Cancer Institute (NCI) and National Institutes of Health (NIH) discusses a recent study that identified genetic variations that may be linked with increased melanoma risk.

Intralesional Combinations Are Promising in Melanoma

Intralesional Combinations Are Promising in Melanoma

October 19th 2017, 5:05pm

World Congress on Melanoma

Intralesional therapies – those delivered directly to the tumor site – used in conjunction with checkpoint inhibitors have shown improvements to the treatment of people with melanoma, says Robert Andtbacka, M.D., in a presentation at the 2017 World Congress of Melanoma.

Don't Let Ovarian Cancer Take Away Your Sex Life

Don't Let Ovarian Cancer Take Away Your Sex Life

July 10th 2017, 9:22pm

Ovarian Cancer National Conference

Many patients with cancer don't hesitate when discussing side effects like fatigue, nausea and neuropathy with their health care provider; however, there is often silence when it boils down to the sexual side effects of their treatment.

PARP Inhibitors Changing the Landscape of Ovarian Cancer Treatment

PARP Inhibitors Changing the Landscape of Ovarian Cancer Treatment

July 10th 2017, 8:22pm

Ovarian Cancer National Conference

The treatment landscape of ovarian cancer continues to change with the recent approvals of new agents.

Audra Moran on the Ovarian Cancer National Conference

Audra Moran on the Ovarian Cancer National Conference

July 10th 2017, 6:18pm

Ovarian Cancer National Conference

Audra Moran, CEO & President of the Ovarian Cancer Research Fund Alliance discusses the Ovarian Cancer National Conference.

David Gershenson on Challenges to Advancing Treatment for Rare Ovarian Cancers

David Gershenson on Challenges to Advancing Treatment for Rare Ovarian Cancers

July 10th 2017, 6:10pm

Ovarian Cancer National Conference

David Gershenson, M.D., of MD Anderson Cancer Center, explains the difficulty of advancing treatment of rare ovarian cancers: malignant ovarian germ cell tumors, sex cord stromal tumors, and types of epithelial tumors such as ovarian clear cell carcinoma, ovarian low-grade serous carcinoma, and mucinous tumors.

Clinical Trials Are the Way Forward for Ovarian Cancer, but They Need Advocates at Every Level

Clinical Trials Are the Way Forward for Ovarian Cancer, but They Need Advocates at Every Level

July 9th 2017, 7:00pm

Ovarian Cancer National Conference

For women with ovarian cancer, the message is clear: participating in clinical trials, even early-phase ones, offers the best hope for better treatments, but efforts are urgently needed at every level to ensure that more of these research opportunities are available.

Fruits, Vegetables and Water are Key Components of a Healthy Diet During and After Ovarian Cancer

Fruits, Vegetables and Water are Key Components of a Healthy Diet During and After Ovarian Cancer

July 9th 2017, 6:44pm

Ovarian Cancer National Conference

Strategies from expert oncology dieticians can help patients to eat an appropriate diet and maintain a healthy weight during and after treatment for ovarian cancer.

Sarah Sciortino on Fertility and Sexuality in Younger Patients with Ovarian Cancer

Sarah Sciortino on Fertility and Sexuality in Younger Patients with Ovarian Cancer

July 9th 2017, 6:23pm

Ovarian Cancer National Conference

Sarah Sciortino, MSW, LSW, Oncology Psychosocial Support Services Program Coordinator at University of Chicago Hospital, discusses the unique concerns that younger patients with ovarian cancer can face.

Mark Gibbons on Caregivers of Patients with Ovarian Cancer

Mark Gibbons on Caregivers of Patients with Ovarian Cancer

July 9th 2017, 6:20pm

Ovarian Cancer National Conference

Mark Gibbons of Caregiver Action Network discusses the emotions caregivers to patients with ovarian cancer may have.

The Road Ahead for Ovarian Cancer

The Road Ahead for Ovarian Cancer

July 9th 2017, 2:43am

Ovarian Cancer National Conference

Opening the 20th Annual Ovarian Cancer National Conference in Chicago, John Moroney, M.D., underscored the challenges that remain in the early detection and treatment of ovarian cancer, but also the tremendous hope that resides in robust clinical trial research.

Nita Lee on Recurrence of Ovarian Cancer

Nita Lee on Recurrence of Ovarian Cancer

July 9th 2017, 1:02am

Ovarian Cancer National Conference

Nita Karnik Lee, MD, MPH, of The University of Chicago Medicine, discusses what patients with ovarian cancer should know about when entering survivorship.

Workshop Aims to Ease the Journey for Family Caregivers of Women With Ovarian Cancer

Workshop Aims to Ease the Journey for Family Caregivers of Women With Ovarian Cancer

July 9th 2017, 12:56am

Ovarian Cancer National Conference

Mark Gibbons, senior director of external programs with the nonprofit Caregiver Action Network, explains the importance of caregivers taking care of themselves while at the Ovarian Cancer National Conference.

Jennifer Lane-Riefler on Financial Assistance Available for Patients with Ovarian Cancer

Jennifer Lane-Riefler on Financial Assistance Available for Patients with Ovarian Cancer

July 8th 2017, 8:14pm

Ovarian Cancer National Conference

Jennifer Lane-Riefler, MCHES, CFm, Executive Director of Cancer Services of Grant County, discusses the financial assistance opportunities available for patients with ovarian cancer.

Previvor Turned Breast Cancer Survivor Shares Her Unexpected Journey

Previvor Turned Breast Cancer Survivor Shares Her Unexpected Journey

June 13th 2017, 12:18am

FORCE Conference

Angela Schmidt Fishbaugh talks about being diagnosed with breast cancer after a mastectomy, changing her from a previvor to survivor.

Pairing PARP Inhibitors With Other Drug Types the Next Frontier for BRCA-Mutated Ovarian Cancers

Pairing PARP Inhibitors With Other Drug Types the Next Frontier for BRCA-Mutated Ovarian Cancers

June 11th 2017, 6:44pm

FORCE Conference

The idea of interfering with DNA’s self-repair capabilities has been at the heart of this decade’s progress in treating ovarian cancer, and the focus now is on combining PARP inhibitors with other types of therapies.

Consider Timing and Presentation When Telling Kids About Familial Predisposition to Cancer

Consider Timing and Presentation When Telling Kids About Familial Predisposition to Cancer

June 11th 2017, 6:03pm

FORCE Conference

There are several issues parents should consider before broaching the subject of genetic cancer risk with their children, explains Karen Hurley, a psychologist with the Cleveland Clinic.

Paying It Forward, so Others Do Not Have to Navigate Hereditary Cancer Risk Alone

Paying It Forward, so Others Do Not Have to Navigate Hereditary Cancer Risk Alone

June 11th 2017, 5:04pm

FORCE Conference

Finding out that you have a BRCA or other mutation that increases your risk of cancer is a frightening and often confusing prospect, but even one supportive voice can make a huge difference.

Alan Blassberg on Being a Male BRCA Carrier

Alan Blassberg on Being a Male BRCA Carrier

June 10th 2017, 9:04pm

FORCE Conference

Alan Blassberg, Director/Producer of Pink and Blue: Colors of Hereditary Cancer, discusses being a male BRCA carrier.

Sharon Bober on Asking Your Doctor About Sexual Health

Sharon Bober on Asking Your Doctor About Sexual Health

June 10th 2017, 8:09pm

FORCE Conference

Sharon Bober, PhD, discusses how patients can ask their doctors about sexual health.

Understanding Mastectomy and Reconstruction Options Can Ease Difficult Decisions

Understanding Mastectomy and Reconstruction Options Can Ease Difficult Decisions

June 10th 2017, 5:56pm

FORCE Conference

Those considering mastectomy to help prevent inherited breast cancer, or because they’ve been diagnosed with the disease, are likely to find themselves sorting through a host of complex questions.

Less Invasive Techniques Gaining Traction in Ovarian Cancer Prevention

Less Invasive Techniques Gaining Traction in Ovarian Cancer Prevention

June 10th 2017, 4:22pm

FORCE Conference

For women genetically predisposed to ovarian cancer, prevention is extremely important. But what are the most effective and least invasive prevention techniques, and when is the best time in life to employ them?

All in the Family: The Importance of Talking About Hereditary Cancer

All in the Family: The Importance of Talking About Hereditary Cancer

June 9th 2017, 11:58pm

FORCE Conference

Knowing that you have an inherited gene mutation can allow you and your family members to look into prevention or detect a cancer at an early stage.

Angela Fishbaugh on Discovering Your Story and Skills

Angela Fishbaugh on Discovering Your Story and Skills

June 9th 2017, 11:15pm

FORCE Conference

Angela Fishbaugh, author of "Angela's Decision," discusses how to discover your skills and story within.

Extending Progression-Free Survival in BRCA-Positive Breast Cancer

Extending Progression-Free Survival in BRCA-Positive Breast Cancer

June 9th 2017, 11:02pm

ASCO Annual Meeting

“This is the first phase 3 study to show an advantage of a PARP inhibitor over standard of care chemotherapy in breast cancer patients with a BRCA mutation,” said principal OLYMPIAD investigator Mark E. Robson, M.D., Clinic Director of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center.

Ilana Cass on Potential Consequences of Preventive Surgery

Ilana Cass on Potential Consequences of Preventive Surgery

June 9th 2017, 10:32pm

FORCE Conference

Ilana Cass, M.D. of Cedars-Sinai Medical Center discusses some of the unknown potential side effects of preventive surgery for ovarian cancer.

Being a 'FORCE' In Hereditary Cancers for 18 Years: An Interview with Executive Director Sue Friedman

Being a 'FORCE' In Hereditary Cancers for 18 Years: An Interview with Executive Director Sue Friedman

June 9th 2017, 8:48pm

FORCE Conference

Sue Friedman, executive director and founder of FORCE, is a hereditary breast cancer survivor herself and has been concentrating on being the support system for others that she didn’t have when she was going through her battle 20 years ago.

XRAYS Separates the Help from the Hype to Make Sense of Cancer Research in the News

XRAYS Separates the Help from the Hype to Make Sense of Cancer Research in the News

June 9th 2017, 8:03pm

FORCE Conference

The program XRAYS is a resource to help patients, survivors and their loved ones make sense of the articles on hereditary cancer they see in the mainstream media and via social media platforms.

Ethical Dilemmas Arise from Genetic Testing for Cancer

Ethical Dilemmas Arise from Genetic Testing for Cancer

June 9th 2017, 5:21pm

FORCE Conference

While genetic testing for cancer has some obvious benefits, it also creates ethical dilemmas in many cases.

Nail Bed Balm Proves Successful in Preventing Chemotherapy-Related Nail Damage

Nail Bed Balm Proves Successful in Preventing Chemotherapy-Related Nail Damage

June 8th 2017, 6:28pm

ASCO Annual Meeting

PolyBalm was effective in mitigating chemotherapy-related nail damage, according to a recent study presented at ASCO.